A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes
2008

Understanding Genetic Factors in Autoimmune Diabetes

publication Evidence: moderate

Author Information

Author(s): Christian S. Parry, Bernard R. Brooks

Primary Institution: National Heart, Lung, and Blood Institute, National Institutes of Health

Hypothesis

A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes.

Conclusion

The study suggests that specific polymorphic markers in HLA molecules correlate with the risk of developing type 1 diabetes.

Supporting Evidence

  • Polar residues at both β9 and β37 accurately distinguish between predisposing and non-predisposing class II HLA molecules.
  • A single polar residue at β37 but not at β9 confers dominant protection.
  • A hydrophobic residue at β37 offers passive resistance (neutral).

Takeaway

Some genes can make people more likely to get diabetes, while others can help protect them from it.

Methodology

The study used structural analysis, computational biophysical, and sequence analyses to explore the relationship between HLA polymorphisms and diabetes susceptibility.

Limitations

The study primarily focuses on specific HLA alleles and may not account for all genetic and environmental factors influencing diabetes.

Digital Object Identifier (DOI)

10.1186/1745-6150-3-42

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication